FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sato Pharmaceutical Zentrip Recall

Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato…

Sato Pharmaceutical Inc. · Torrance, CA

Risk level
Class III
Reported by FDA
Nov 20, 2019
Recall ID
D-0322-2020
Check your lot numberHow we source this data

Summary

Sato Pharmaceutical recalled Zentrip starting Oct 1, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0322-2020 on Nov 20, 2019. Reason: Subpotent Drug. Status: Terminated.

Why it was recalled

Subpotent Drug

Product description

Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603

Lot numbers, UPCs & expiration codes

Lot #: TXWW, TXTW, Exp. date Dec 2019; AXPS, AXLS, AXBS AXNS, Exp. date Oct 2021; AXZL, AXAL, AXTL, AXWL, Exp. date Jun 2021.

Where it was sold

Nationwide within the United States, Guam and Saipan

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0322-2020
Classification
Class III
Status
Terminated
Recall initiated
Oct 1, 2019
FDA report date
Nov 20, 2019
Quantity
21,864 units
Recall type
Voluntary: Firm initiated
Recalling firm
Sato Pharmaceutical Inc.

Original FDA data

Every field from FDA enforcement report D-0322-2020, exactly as published.

Show all FDA fields
City
Torrance
State
CA
Status
Terminated
Country
United States
Event ID
83964
Address
20695 S Western Ave Ste 240
Code information
Lot #: TXWW, TXTW, Exp. date Dec 2019; AXPS, AXLS, AXBS AXNS, Exp. date Oct 2021; AXZL, AXAL, AXTL, AXWL, Exp. date Jun 2021.
Postal code
90501-1834
Report date
Nov 20, 2019
Product type
Drugs
Recall number
D-0322-2020
Classification
Class III
Recalling firm
Sato Pharmaceutical Inc.
Product quantity
21,864 units
Termination date
Aug 18, 2020
Reason for recall
Subpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 49873-803-01. UPC 4987301603
Distribution pattern
Nationwide within the United States, Guam and Saipan
Recall initiation date
Oct 1, 2019
Initial firm notification
Letter
Center classification date
Nov 13, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0322-2020, published Nov 20, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls